EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint Enterprise Value : 294.00M for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 294.00M |
| August 20, 2026 | 300.80M |
| August 19, 2026 | 377.28M |
| August 18, 2026 | 306.75M |
| August 17, 2026 | 255.76M |
| August 14, 2026 | 1.095B |
| August 13, 2026 | 987.45M |
| August 12, 2026 | 991.70M |
| August 11, 2026 | 950.91M |
| August 10, 2026 | 952.61M |
| August 07, 2026 | 1.022B |
| August 06, 2026 | 932.21M |
| August 05, 2026 | 882.92M |
| August 04, 2026 | 833.63M |
| August 03, 2026 | 897.37M |
| July 31, 2026 | 882.92M |
| July 30, 2026 | 934.76M |
| July 29, 2026 | 854.88M |
| July 28, 2026 | 858.28M |
| July 27, 2026 | 896.52M |
| July 24, 2026 | 877.82M |
| July 23, 2026 | 901.62M |
| July 22, 2026 | 917.76M |
| July 21, 2026 | 950.91M |
| July 20, 2026 | 917.76M |
| Date | Value |
|---|---|
| July 17, 2026 | 972.15M |
| July 16, 2026 | 950.06M |
| July 15, 2026 | 1.019B |
| July 14, 2026 | 1.009B |
| July 13, 2026 | 1.055B |
| July 10, 2026 | 1.093B |
| July 09, 2026 | 1.103B |
| July 08, 2026 | 1.032B |
| July 07, 2026 | 1.033B |
| July 06, 2026 | 1.069B |
| July 02, 2026 | 1.030B |
| July 01, 2026 | 963.23M |
| June 30, 2026 | 1.057B |
| June 29, 2026 | 977.29M |
| June 26, 2026 | 939.74M |
| June 25, 2026 | 943.91M |
| June 24, 2026 | 1.001B |
| June 23, 2026 | 999.82M |
| June 22, 2026 | 945.58M |
| June 18, 2026 | 933.06M |
| June 17, 2026 | 897.18M |
| June 16, 2026 | 874.64M |
| June 15, 2026 | 807.88M |
| June 12, 2026 | 887.16M |
| June 11, 2026 | 842.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ocular Therapeutix, Inc. | 1.914B |
| Eli Lilly & Co. | 1.228T |
| Elanco Animal Health, Inc. | 15.36B |
| Amylyx Pharmaceuticals, Inc. | 4.060B |
| Nuvation Bio, Inc. | 2.180B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -94.47M |
| Revenue (Quarterly) | 0.507M |
| Total Expenses (Quarterly) | 94.98M |
| EPS Diluted (Quarterly) | -1.092 |
| Gross Profit Margin (Quarterly) | -36.09% |
| Profit Margin (Quarterly) | -18.63K% |
| Earnings Yield | -76.79% |
| Normalized Earnings Yield | -76.79 |